Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.
NCT ID: NCT00813397
Last Updated: 2015-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
210 participants
INTERVENTIONAL
2008-09-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Safety of Sepraspray in Open Abdominal Surgery
NCT00778479
Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical Adhesions
NCT00665730
Seprafilm® Adhesion Barrier and Cesarean Delivery
NCT00565643
Seprafilm in Open Abdomens: a Study of Wound and Adhesion Characteristics in Trauma Damage Control Patients
NCT01594385
PMCF Study for COSEAL® in Gynecologic Surgery
NCT05996809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepraspray
Receive Sepraspray
Sepraspray
Max. 10g of Sepraspray
Control
No Treatment, No Placebo
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sepraspray
Max. 10g of Sepraspray
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Genzyme, a Sanofi Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Genzyme, a Sanofi Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Nord
Amiens, , France
Hopital Avicenne
Bobingy, , France
Hopital Beaujon
Clichy, , France
Centre Hospitalier Simone Veil
Eaubonne, , France
Hopital Nord
Marseille, , France
CHR Nantes-Hopital Hotel Dieu
Nantes, , France
CHU Hopital de le'Archet
Nice, , France
Institut Mutualiste Montsouris
Paris, , France
CHU Bordeaux-Hopital du Haut Leveque
Pessac, , France
CHU Lyon Sud
Pierre-Bénite, , France
Centre Hospitalier Intercommunal de Poissy Saint-German
Poissy, , France
CHU Charles Nicolle
Rouen, , France
CHU Bordeaux Saint Andre
Talence, , France
Hopital Purpan
Toulouse, , France
CHU Hopital Trousseau
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berdah SV, Mariette C, Denet C, Panis Y, Laurent C, Cotte E, Huten N, Le Peillet Feuillet E, Duron JJ. A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery. Trials. 2014 Oct 27;15:413. doi: 10.1186/1745-6215-15-413.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SSPRAY00608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.